{"name":"Mostafa Hassanein, Msc","slug":"mostafa-hassanein-msc","ticker":"","exchange":"","domain":"","description":"Mostafa Hassanein, Msc is a specialized biotech company focused on the development and commercialization of autologous platelets rich plasma, a marketed product used in various therapeutic areas.","hq":"","founded":0,"employees":"N/A","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Immunology","slug":"immunology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Autologous platelets rich plasma","genericName":"Autologous platelets rich plasma","slug":"autologous-platelets-rich-plasma","indication":"Osteoarthritis (knee, shoulder, hip)","status":"marketed"}]}],"pipeline":[{"name":"Autologous platelets rich plasma","genericName":"Autologous platelets rich plasma","slug":"autologous-platelets-rich-plasma","phase":"marketed","mechanism":"Autologous platelet-rich plasma (PRP) delivers concentrated growth factors and cytokines from the patient's own platelets to promote tissue repair and reduce inflammation.","indications":["Osteoarthritis (knee, shoulder, hip)","Tendon and ligament injuries","Muscle injuries","Chronic wounds","Hair loss (androgenetic alopecia)"],"catalyst":""}],"recentEvents":[],"realNews":[],"patents":[],"drugCount":1,"phaseCounts":{"marketed":1},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}